Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06264934 | An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical Capacitance Tomography Scanner(DiCECT) | unknown | — | 90 | Zedsen LimitedINDUSTRY | 1 | Jun 7, 2024 | clinicaltrials |
| NCT06439940 | Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs | unknown | — | 364 | Oncoliq US IncINDUSTRY | 1 | Jun 7, 2024 |
| clinicaltrials |
| NCT06448169 | Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer | unknown | — | 200 | Shandong UniversityOTHER | 0 | Jun 7, 2024 | clinicaltrials |
| NCT06448897 | Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques. | unknown | — | 4,000 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT04215003 | A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC | unknown | Phase 1 / Phase 2 | 20 | Fudan UniversityOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT06018896 | Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer(PTCA199-4) | unknown | Phase 2 | 20 | Fudan UniversityOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT06445257 | A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL | unknown | N/A | 30 | Huai'an First People's HospitalOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT06445621 | Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test(FOLL-OV) | unknown | — | 125 | Uppsala University HospitalOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT04506359 | Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer Patients | unknown | N/A | 300 | National Taiwan University HospitalOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT05638451 | Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients | unknown | Phase 2 | 30 | Zhujiang HospitalOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06313541 | Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy | unknown | Phase 2 | 146 | Fudan UniversityOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06428682 | Role of TXA in Patients Undergoing Breast Free Flap Reconstruction | unknown | Phase 4 | 100 | University of VirginiaOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06442215 | Selection of Surgical Technique in Rectal Cancer(TECARE) | unknown | — | 333 | Institut d'Investigació Biomèdica de Girona Dr. Josep TruetaOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06443307 | Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan | unknown | — | 933 | Peking UniversityOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT02061800 | CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant | unknown | Phase 1 / Phase 2 | 14 | Diane GeorgeOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT02344472 | Detect V / CHEVENDO (Chemo vs. Endo) | unknown | Phase 3 | 271 | Prof. Wolfgang JanniOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT02441933 | Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial) | unknown | Phase 3 | 878 | Yonsei UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT04322578 | Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC(CONFIRM) | unknown | Phase 2 | 120 | Hunan Province Tumor HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05246163 | ARTIficial Intelligence-based Smartphone Application for Skin Cancer Detection(ARTIS) | unknown | — | 2,500 | University Hospital, GhentOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05304234 | Liver Cancer Disparities in American Indian and Alaska Native Persons | unknown | Phase 2 | 200 | University of WashingtonOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05818449 | Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)(DigiNet) | unknown | N/A | 850 | University of CologneOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06136065 | 68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors(FAPI) | unknown | Phase 2 | 100 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06422533 | Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients | unknown | N/A | 226 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06424080 | Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors. | unknown | N/A | 20 | Menoufia UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06434753 | Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease. | unknown | Phase 3 | 300 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06441240 | Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.(NEORISK) | unknown | — | 933 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06441292 | Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation | unknown | N/A | 602 | Shanghai East HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06441357 | Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter | unknown | — | 2,000 | Tang-Du HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06441513 | The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome | unknown | N/A | 130 | Peking University Third HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06442709 | Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients | unknown | N/A | 100 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT02993198 | A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging | unknown | Phase 2 | 134 | Northwestern UniversityOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT06254196 | Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies(Telenursing) | unknown | N/A | 40 | Regina Elena Cancer InstituteOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT06416943 | 3D Port-A Catheter Model for New Staff | unknown | N/A | 50 | Fu Jen Catholic UniversityOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT06440122 | The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs) | unknown | — | 100 | King's College Hospital NHS TrustOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT03356236 | Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation | unknown | — | 828 | Yue HanOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT04641819 | Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients | unknown | Phase 4 | 1,127 | ShuGuang HospitalOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06250010 | Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence | unknown | — | 30 | Regina Elena Cancer InstituteOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06436885 | An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer | unknown | Early Phase 1 | 39 | Henan Cancer HospitalOTHER_GOV | 1 | May 31, 2024 | clinicaltrials |
| NCT06436976 | The Effect of Probiotics ATG-F4 in Cancer Patients | unknown | Phase 2 | 30 | Chungnam National University HospitalOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06437496 | 68Ga-AAZTA-093 PET/CT: First-in-human Study | unknown | Early Phase 1 | 30 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06437678 | Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06438055 | Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results | unknown | N/A | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | May 31, 2024 | clinicaltrials |
| NCT06433726 | A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors | unknown | Phase 1 | 60 | Chengdu Baiyu Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 30, 2024 | clinicaltrials |
| NCT06434090 | Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 74 | Sun Yat-sen UniversityOTHER | 1 | May 30, 2024 | clinicaltrials |
| NCT06434467 | The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma | unknown | Phase 3 | 83 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | May 30, 2024 | clinicaltrials |
| NCT06435533 | Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis(coldAPC) | unknown | N/A | 10 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | May 30, 2024 | clinicaltrials |
| NCT06435559 | CHEmotherapy and Cognitive Deterioration in Patients With Operable Breast Cancer: Impact of Cognitive Rehabilitation (CHEMOFOG)(CHEMOFOG) | unknown | N/A | 128 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 0 | May 30, 2024 | clinicaltrials |
| NCT06435741 | Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe. | unknown | N/A | 30 | Peking University Cancer Hospital & InstituteOTHER | 0 | May 30, 2024 | clinicaltrials |
| NCT06436040 | Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma | unknown | — | 40 | Tang-Du HospitalOTHER | 1 | May 30, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jun 7, 2024source: clinicaltrials